-
Beyond the Mean: Do Distribution-Based Metrics Offer Greater Insight Into Predictors of Societal Health Preferences? A Secondary Analysis of 42 EQ-5D-5L Value Sets
Sep 9, 2025, 16:22 PM -
The Impact of Adherence on the Value Assessment of Cardiovascular Interventions: A Systematic Literature Review of Economic Evaluations
Sep 9, 2025, 16:22 PM -
Director Primary Data Collection
Sep 9, 2025, 16:22 PM -
Health Technologies Using Artificial Intelligence: What Is Being Assessed in the UK by NICE?
Sep 9, 2025, 16:22 PM -
Evolving JCA Perspectives From EU Stakeholders and the Impact on Manufacturers
Sep 9, 2025, 16:22 PM -
Potential Public Health Benefits of Recombinant Influenza Vaccines in Older Adults in England and Wales
Sep 9, 2025, 16:22 PM -
Environmental Impact of Prefilled and Reusable Injectable Systems: A Systematic Review
Sep 9, 2025, 16:22 PM -
Systematic Review of Value Assessment Frameworks for Digital Health Interventions: Toward a Multidimensional Evaluation Approach
Sep 9, 2025, 16:22 PM -
Landscape of Data Sources for Real-World Observational Studies: Focus on the French Context
Sep 9, 2025, 16:22 PM -
Roflumilast Foam 0.3% in Patients With Psoriasis of the Scalp and Body: Improvements in Patient-Reported Outcomes and Quality of Life
Sep 9, 2025, 16:22 PM -
Effectiveness of Vonoprazan on Health-Related Quality of Life and Sleep Quality in Chinese Patients With Reflux Esophagitis: Post Hoc Analysis of the VIEW Study
Sep 9, 2025, 16:22 PM -
Factors Associated With the Highest Costs Among US Adults With Primary Biliary Cholangitis
Sep 9, 2025, 16:22 PM -
Cost Calculator of Immunotherapies in 1L Endometrial Cancer Treatment for the Deficient Mismatch Repair, Proficient Mismatch Repair, and Intention-to-Treat Populations From the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Access and Pricing Timelines for Innovative Medicines in the US, Europe, and Japan Pre- and Post-Pricing Reform 2021-2025
Sep 9, 2025, 16:22 PM -
Extending Survival in Glioblastoma: Real-World Evidence of Post-Progression Benefit From Tumor-Treating Fields Therapy
Sep 9, 2025, 16:22 PM -
Applying Simulation-Guided Trial Design Principles to Prospectively Plan Target Trial Emulation of a Cluster Randomized Trial for Vaccine Coverage
Sep 9, 2025, 16:22 PM -
Economic Burden Of Primary Biliary Cholangitis (PBC) in Spain
Sep 9, 2025, 16:22 PM -
Physician Perspectives on Unmet Need and Treatment Options Among Patients With Relapsed Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) in Canada: Findings From Qualitative Interviews
Sep 9, 2025, 16:22 PM -
Artificial Intelligence-Based Population, Intervention, Comparator, and Outcome (PICO) Prediction for European Union (EU) Joint Clinical Assessment (JCA)
Sep 9, 2025, 16:22 PM -
Evaluating the Feasibility and Acceptability of a Personalized Endpoint: A Prospective Mixed Methods Study of Inventory-Facilitated Goal Attainment Scaling
Sep 9, 2025, 16:22 PM
